Please Wait.....
Report
Global Alzheimer'S Disease Therapeutics & Diagnostics Market Forecast 2022-2030
Market Report I 2022-06-21 I 235 Pages I Inkwood Research
KEY FINDINGS
The global Alzheimer's disease therapeutics & diagnostics market is anticipated to grow at a 6.61% CAGR during the estimation period between 2022 to 2030. The market growth is accelerated by the rise in the pervasiveness of Alzheimer's disease, emerging novel diagnostic technologies, and the increasing number of pipeline drugs.
MARKET INSIGHTS
Alzheimer's is a neurodegenerative disease characterized by chronic inflammation and accumulation of beta-amyloid peptides. The elderly usually suffer from Alzheimer's disease, which gradually damages their thinking skills and memory, eventually destroying their ability to perform the simplest daily tasks. Alzheimer's disease is the major reason for dementia among the older population. Therefore, the rising geriatric population is a key driver for the global Alzheimer's disease therapeutics and diagnostics market.
Several novel diagnostics technologies have been discovered for Alzheimer's disease (AD), including the invention that identifies mutated proteins in subcellular compartments. This invention describes these mutations that lead to the redistribution of crucial cellular organelles.
Furthermore, alteration of organelles distribution can be a powerful diagnostic tool, an assay to screen novel therapeutic compounds for Alzheimer's disease. This technology's advantage includes identifying mutated proteins, which are directly involved in the genesis of AD. Thus, there is potential for providing a superior AD diagnosis compared to current diagnostic tests.
REGIONAL INSIGHTS
The global Alzheimer's disease therapeutics & diagnostics market assessment entails the analysis of Europe, Asia-Pacific, North America, and Rest of World. The Asia-Pacific region is anticipated to propel with the highest CAGR by 2030, owing to the rapidly increasing geriatric population and government initiative to develop medicines to cure AD.
COMPETITIVE INSIGHTS
The competition in the global market is significantly high owing to the presence of generic medicines. Furthermore, strong competition exists among the key players in developing new diagnostics methodologies and treatments. However, the industry is observing meaningful strategic partnerships to enhance market presence.
Some important global players include Merck & Co Inc, Cognoptix Inc, Eli Lilly & Company, Johnson & Johnson, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS
3.2. KEY DRIVERS
3.2.1. GROWING GERIATRIC POPULATION
3.2.2. RISING PERVASIVENESS OF ALZHEIMER'S DISEASE
3.2.3. EMERGING NOVEL DIAGNOSTIC TECHNOLOGIES
3.2.4. INCREASING PIPELINE DRUGS
3.3. KEY RESTRAINTS
3.3.1. FAILURE OF THE LATE-STAGE DRUGS
3.3.2. STRINGENT GOVERNMENT REGULATIONS
3.3.3. LACK OF THE AVAILABILITY OF SURROGATE MARKERS
4. KEY ANALYTICS
4.1. TIMELINE OF ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET
4.2. PHASES AND STERNNESS OF ALZHEIMER'S DISEASE
4.3. IMPACT OF COVID-19 ON ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET
4.4. KEY MARKET TRENDS
4.5. PORTER'S FIVE FORCES ANALYSIS
4.5.1. BUYERS POWER
4.5.2. SUPPLIERS POWER
4.5.3. SUBSTITUTION
4.5.4. NEW ENTRANTS
4.5.5. INDUSTRY RIVALRY
4.6. KEY BUYING CRITERIA
4.7. SUPPLY CHAIN ANALYSIS
4.8. OPPORTUNITY MATRIX
4.9. VENDOR LANDSCAPE
5. MARKET BY THERAPEUTICS & DIAGNOSTICS
5.1. THERAPEUTICS
5.1.1. DRUGS
5.1.1.1. MARKETED DRUGS
5.1.1.2. PIPELINE DRUGS
5.1.2. DISEASE STAGE
5.1.2.1. LATE-STAGE: SEVERE AD
5.1.2.2. EARLY/MIDDLE STAGE: MILD TO MODERATE AD
5.1.2.3. PRODROMAL STAGE
5.1.3. GENERIC & BRANDED
5.1.3.1. BRANDED
5.1.3.2. GENERIC
5.2. DIAGNOSTICS
5.2.1. LUMBAR PUNCTURE TEST
5.2.2. POSITRON EMISSION TOMOGRAPHY
5.2.3. ELECTROENCEPHALOGRAPHY
5.2.4. MAGNETIC RESONANCE IMAGING
5.2.5. COMPUTED TOMOGRAPHY
5.2.6. BLOOD TEST
5.2.7. OTHER DIAGNOSTICS
6. GEOGRAPHICAL ANALYSIS
6.1. NORTH AMERICA
6.1.1. MARKET SIZE & ESTIMATES
6.1.2. KEY GROWTH ENABLERS
6.1.3. KEY CHALLENGES
6.1.4. KEY PLAYERS
6.1.5. COUNTRY ANALYSIS
6.1.5.1. UNITED STATES
6.1.5.2. CANADA
6.2. EUROPE
6.2.1. MARKET SIZE & ESTIMATES
6.2.2. KEY GROWTH ENABLERS
6.2.3. KEY CHALLENGES
6.2.4. KEY PLAYERS
6.2.5. COUNTRY ANALYSIS
6.2.5.1. UNITED KINGDOM
6.2.5.2. GERMANY
6.2.5.3. FRANCE
6.2.5.4. ITALY
6.2.5.5. BELGIUM
6.2.5.6. POLAND
6.2.5.7. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET SIZE & ESTIMATES
6.3.2. KEY GROWTH ENABLERS
6.3.3. KEY CHALLENGES
6.3.4. KEY PLAYERS
6.3.5. COUNTRY ANALYSIS
6.3.5.1. CHINA
6.3.5.2. JAPAN
6.3.5.3. INDIA
6.3.5.4. SOUTH KOREA
6.3.5.5. INDONESIA
6.3.5.6. THAILAND
6.3.5.7. VIETNAM
6.3.5.8. AUSTRALIA & NEW ZEALAND
6.3.5.9. REST OF ASIA-PACIFIC
6.4. REST OF WORLD
6.4.1. MARKET SIZE & ESTIMATES
6.4.2. KEY GROWTH ENABLERS
6.4.3. KEY CHALLENGES
6.4.4. KEY PLAYERS
6.4.5. REGIONAL ANALYSIS
6.4.5.1. LATIN AMERICA
6.4.5.2. MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. KEY STRATEGIC DEVELOPMENTS
7.1.1. MERGERS & ACQUISITIONS
7.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
7.1.3. PARTNERSHIPS & AGREEMENTS
7.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
7.2. COMPANY PROFILES
7.2.1. ALLERGAN PLC (ACQUIRED BY ABBVIE)
7.2.2. AMARANTUS BIOSCIENCE HOLDINGS INC
7.2.3. BAXTER INTERNATIONAL INC
7.2.4. BIOGEN INC
7.2.5. COGNOPTIX INC
7.2.6. EISAI CO LTD
7.2.7. ELI LILLY & COMPANY
7.2.8. F HOFFMANN-LA ROCHE
7.2.9. GE HEALTHCARE
7.2.10. JOHNSON & JOHNSON
7.2.11. LUPIN LIMITED
7.2.12. MERCK & CO INC
7.2.13. NOVARTIS AG
7.2.14. PFIZER INC
7.2.15. SIEMENS HEALTHINEERS AG
7.2.16. SUN PHARMACEUTICALS INDUSTRIES LTD
7.2.17. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
7.2.18. ZYDUS CADILA
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS
TABLE 2: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS & DIAGNOSTICS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS & DIAGNOSTICS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 4: GLOBAL THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: GLOBAL THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY DRUGS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY DRUGS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: GLOBAL MARKETED DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: GLOBAL MARKETED DRUGS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: GLOBAL PIPELINE DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: GLOBAL PIPELINE DRUGS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY DISEASE STAGE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY DISEASE STAGE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: GLOBAL LATE-STAGE: SEVERE AD MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: GLOBAL LATE-STAGE: SEVERE AD MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: GLOBAL EARLY/MIDDLE STAGE: MILD TO MODERATE AD MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: GLOBAL EARLY/MIDDLE STAGE: MILD TO MODERATE AD MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: GLOBAL PRODROMAL STAGE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 19: GLOBAL PRODROMAL STAGE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 20: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY GENERIC & BRANDED, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 21: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY GENERIC & BRANDED, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 22: GLOBAL BRANDED MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 23: GLOBAL BRANDED MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 24: GLOBAL GENERIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 25: GLOBAL GENERIC MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 26: GLOBAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 27: GLOBAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 28: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 29: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 30: GLOBAL LUMBAR PUNCTURE TEST MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 31: GLOBAL LUMBAR PUNCTURE TEST MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 32: GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 33: GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 34: GLOBAL ELECTROENCEPHALOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 35: GLOBAL ELECTROENCEPHALOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 36: GLOBAL MAGNETIC RESONANCE IMAGING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 37: GLOBAL MAGNETIC RESONANCE IMAGING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 38: GLOBAL COMPUTED TOMOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 39: GLOBAL COMPUTED TOMOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 40: GLOBAL BLOOD TEST MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 41: GLOBAL BLOOD TEST MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 42: GLOBAL OTHER DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 43: GLOBAL OTHER DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 44: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 45: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 46: NORTH AMERICA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 47: NORTH AMERICA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 48: LEADING PLAYERS OPERATING IN NORTH AMERICA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET
TABLE 49: EUROPE ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 50: EUROPE ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 51: LEADING PLAYERS OPERATING IN EUROPE ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET
TABLE 52: ASIA-PACIFIC ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 53: ASIA-PACIFIC ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 54: LEADING PLAYERS OPERATING IN ASIA-PACIFIC ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET
TABLE 55: REST OF WORLD ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 56: REST OF WORLD ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 57: LEADING PLAYERS OPERATING IN REST OF WORLD ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET
TABLE 58: LIST OF MERGERS & ACQUISITIONS
TABLE 59: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 60: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 61: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
LIST OF FIGURES
FIGURE 1: PIPELINE DRUGS RELATED TO ALZHEIMER'S DISEASE
FIGURE 2: KEY MARKET TRENDS
FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
FIGURE 4: KEY BUYING CRITERIA
FIGURE 5: SUPPLY CHAIN ANALYSIS
FIGURE 6: OPPORTUNITY MATRIX
FIGURE 7: VENDOR LANDSCAPE
FIGURE 8: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY THERAPEUTICS & DIAGNOSTICS, IN 2021
FIGURE 9: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY THERAPEUTICS, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DRUGS, IN 2021
FIGURE 11: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY MARKETED DRUGS, 2022-2030 (IN $ MILLION)
FIGURE 12: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY PIPELINE DRUGS, 2022-2030 (IN $ MILLION)
FIGURE 13: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY DISEASE STAGE, IN 2021
FIGURE 14: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY LATE-STAGE: SEVERE AD, 2022-2030 (IN $ MILLION)
FIGURE 15: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY EARLY/MIDDLE STAGE: MILD TO MODERATE AD, 2022-2030 (IN $ MILLION)
FIGURE 16: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY PRODROMAL STAGE, 2022-2030 (IN $ MILLION)
FIGURE 17: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, GROWTH POTENTIAL, BY GENERIC & BRANDED, IN 2021
FIGURE 18: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY BRANDED, 2022-2030 (IN $ MILLION)
FIGURE 19: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS MARKET, BY GENERIC, 2022-2030 (IN $ MILLION)
FIGURE 20: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTICS, 2022-2030 (IN $ MILLION)
FIGURE 21: GLOBAL ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, GROWTH POTENTIAL, BY DIAGNOSTICS, IN 2021
FIGURE 22: GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY LUMBAR PUNCTURE TEST, 2022-2030 (IN $ MILLION)
FIGURE 23: GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY POSITRON EMISSION TOMOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 24: GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY ELECTROENCEPHALOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 25: GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY MAGNETIC RESONANCE IMAGING, 2022-2030 (IN $ MILLION)
FIGURE 26: GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY COMPUTED TOMOGRAPHY, 2022-2030 (IN $ MILLION)
FIGURE 27: GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY BLOOD TEST, 2022-2030 (IN $ MILLION)
FIGURE 28: GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY OTHER DIAGNOSTICS, 2022-2030 (IN $ MILLION)
FIGURE 29: NORTH AMERICA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 30: UNITED STATES ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: CANADA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: EUROPE ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 33: UNITED KINGDOM ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: GERMANY ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: FRANCE ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: ITALY ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: BELGIUM ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: POLAND ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: REST OF EUROPE ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 41: CHINA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 42: JAPAN ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: INDIA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 44: SOUTH KOREA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 45: INDONESIA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 46: THAILAND ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 47: VIETNAM ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 48: AUSTRALIA & NEW ZEALAND ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 49: REST OF ASIA-PACIFIC ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 50: REST OF WORLD ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 51: LATIN AMERICA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 52: MIDDLE EAST & AFRICA ALZHEIMER'S DISEASE THERAPEUTICS & DIAGNOSTICS MARKET, 2022-2030 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security